Tag: 30-month stay
30-Month Stay: How Litigation Delays Generic Drug Approval
Dec, 11 2025
The 30-month stay under the Hatch-Waxman Act lets brand drug companies delay generic approval by filing patent lawsuits. This legal tool, meant to protect innovation, often extends drug monopolies by years-costing patients billions.
Read Article→
online pharmacy
generic drugs
side effects
medication safety
dosage
counterfeit drugs
Hatch-Waxman Act
medication side effects
generic substitution
medication adherence
benefits
pharmacy alternatives
alternatives
family support
Parkinson's disease
motor symptoms
blood sugar control
warfarin
chronic kidney disease
anticoagulant safety